explore -WSS

explore

author：explore 2025-09-27 23:11:50 - browse：47576

Miniature people figurines standing in a group looking down. -- health tech coverage from STAT — Adobe

In less than two years, digital health’s high-flying class of public debuts have landed with a resounding thud.

Accelerated by the pandemic’s forced adoption of telehealth and other digital health solutions, 2021 saw more than 30 health technology startups go public, raising hundreds of millions and in some cases billions of dollars. Today, three members of the class of 2021 have gone bankrupt. Twelve companies have lost more than 90% of their initial value, including Bright Health Group, Cue Health, and Better Therapeutics. And dangerously low reserves have inspired desperate moves to slash costs, drum up liquidity, and find buyers.

Most recently, the bankruptcy of digital primary care company Babylon Health has drawn attention to the plight of newly-public health tech companies, and how the froth of dealmaking at the height of the pandemic led to overblown valuations. Before its debut in June 2021, Babylon was valued at $4.2 billion; after filing for bankruptcy in August, its U.K. telemedicine business was sold for just over $600,000.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Juul documents reveal insider tactics on political lobbying

WSS

Hospitals owned by private equity see complications spike 25%

Drinking less cuts risk of oral cavity, esophageal cancer: Report

Abbott's new heart device gets FDA advisory panel nod

Doctors on social media are being harassed and cyberbullied

Bernie Sanders gets little from pharma CEOs on drug prices

Grail spinoff by Illumina should end disastrous merger attempt

knowledge

explore

knowledge

Anesthesiologist group: stop taking Ozempic before surgery

Eli Lilly reports tirzepatide MASH success during Q4 earnings

How one medical school became remarkably diverse

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

Tori Bowie and the unacceptable rates of Black maternal death

Long Covid research funding gets a major boost from NIH

The cancer drug shortage isn’t new — and neither are the solutions

Juul documents reveal insider tactics on political lobbying

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Long Covid research funding gets a major boost from NIH

Wikipedia

Bernie Sanders gets little from pharma CEOs on drug prices

Websites selling Wegovy, Zepbound ingredients targeted by FDA

Three trends to watch in biotech in 2024

Why health records don't always know when patients are dead

Prime Medicine, Myeloid Therapeutics clash over genome

ACIP vaccine advisory panel sees its vacancies filled

hotspot

focus

hotspot

leisure time